Clinical Trial Update: A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for BT02 in patients with advanced malignant melanoma; the study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma
• Solid Tumor

Drugs mentioned

• BT02

Snippet

Sponsor: Biotroy Therapeutics | Conditions: Advanced Melanoma, Advanced Solid Tumor | Phase 1 | Status: NOT_YET_RECRUITING